Skip to main content Skip to section navigation Skip to footer
SCYNEXIS, Inc. SCYNEXIS, Inc.
  • About Us
    • Our Mission
    • Leadership
    • Partnerships
    • Careers
    • Contact Us
  • Our Science
    • Ibrexafungerp
    • Life-threatening Infections
    • Community Infections
    • Pipeline
    • Publications and Presentations
  • Our Product
  • News
    • News
    • Events
  • Careers
  • Investors
    • News & Events
    • Company Info
    • Financial Info
    • Stock Info
    • SEC Filings
    • Governance

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Presentations
    • Email Alerts
  • Company Info
    • Overview
    • Leadership
    • Contacts
    • FAQ
    • Tear Sheet
  • Financial Info
    • Overview
    • Financial Results
    • Key Ratios
    • Investor Calculator
  • Stock Info
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
    • Investor Calculator
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Filings
    • Quarterly Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Presentations
  • Email Alerts
May 26, 2015 8:30am EDT

SCYNEXIS, Inc. to Present at Jefferies 2015 Healthcare Conference

May 15, 2015 8:30am EDT

SCYNEXIS, Inc. Reports First Quarter 2015 Financial Results

May 14, 2015 8:30am EDT

SCYNEXIS Appoints David Angulo, M.D., as Chief Medical Officer

Apr 22, 2015 10:30pm EDT

SCYNEXIS Announces Pricing of Public Offering of Common Stock

Apr 20, 2015 7:40am EDT

SCYNEXIS Announces Launch of Public Offering of Common Stock

Mar 30, 2015 8:30am EDT

SCYNEXIS, Inc. Reports Full Year 2014 Financial Results

Mar 12, 2015 8:30am EDT

SCYNEXIS, Inc. to Present at Jefferies 2015 Antibiotic Summit

Feb 27, 2015 8:30am EST

SCYNEXIS, Inc. Appoints Steven C. Gilman, Ph.D., to Board of Directors

Feb 19, 2015 8:30am EST

SCYNEXIS, Inc. to Present at RBC Capital Markets 2015 Healthcare Conference

Feb 06, 2015 7:15am EST

SCYNEXIS Names Marco Taglietti, M.D., Chief Executive Officer

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 24
  • Page 25
  • Page 26
  • Page 27
  • Page 28
  • Page 29
  • Page 30
  • Page 31
  • Page 32
  • Page 33
  • …
  • Page 35
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Company Profile
  • Contacts
  • RSS News Feed
Scynexis
1 Evertrust Plaza, Jersey City, NJ 07302
(201) 884-5485
Facebook Twitter Linkedin
  • Patents
  • Expanded Access
  • Privacy Policy
  • Disclaimer
  • Sitemap
© 2025 SCYNEXIS, Inc. All Rights Reserved.